Davis Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Davis Capital Management's CORT Position: Q3 2026 in Review
Davis Capital Management sold out of Corcept Therapeutics (CORT) in Q3 2026, closing a stake of 5 shares — an estimated $435 sold.
Davis Capital Management first reported a position in CORT in Q2 2026 and held it in 1 quarter. The position peaked at $435 in Q2 2026. 463 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Davis Capital Management reported no remaining Corcept Therapeutics position as of Q3 2026 after selling out during the quarter.
- Davis Capital Management sold 5 Corcept Therapeutics shares in Q3 2026, an estimated $435.
- Davis Capital Management first reported a position in Corcept Therapeutics in Q2 2026 and held it in 1 quarter.
- Davis Capital Management's Corcept Therapeutics position peaked at $435 in Q2 2026.
- 463 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.